Comanche Biopharma

formerly Comanche

Making every pregnancy around the world safer

Concord, United States · Founded 2020 · $115.0M raised

Employees
11–50
Founded
2020
Business Model
B2B
Total Funding
$115.0M
Last Round
$40.0M Series CJan 2026
Rounds
3

About

Comanche Biopharma is a clinical-stage biopharmaceutical company developing CBP-4888, an investigational siRNA medicine for preterm preeclampsia. Founded in 2020 and headquartered in Concord, MA, Comanche's mission is to develop and make globally available the first therapy targeting a root cause of preeclampsia — a life-threatening pregnancy complication affecting millions of women worldwide. The EMA granted Orphan Drug Designation for CBP-4888 in 2025.

Summary

Comanche Biopharma is a Biotech company based in Concord, United States, founded in 2020. It has raised $115.0M in total across 3 rounds, most recently a $40.0M Series C round in Jan 2026. Investors include Atlas Venture, New Enterprise Associates and GV.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series CSeries CJan 2026
$40.0M

Sign up to see all 3 rounds

Series A through Series C — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Comanche Biopharma on Indexed.vc
<a href="https://indexed.vc/companies/comanche-biopharma"><img src="https://indexed.vc/api/badge/company/comanche-biopharma" alt="Comanche Biopharma on Indexed.vc" width="260" height="76" /></a>